ATE457730T1 - Verabreichung von produkten des 5-lipoxygenase synthesewegs zur behandlung von mikrobiellen infektionen - Google Patents

Verabreichung von produkten des 5-lipoxygenase synthesewegs zur behandlung von mikrobiellen infektionen

Info

Publication number
ATE457730T1
ATE457730T1 AT05016311T AT05016311T ATE457730T1 AT E457730 T1 ATE457730 T1 AT E457730T1 AT 05016311 T AT05016311 T AT 05016311T AT 05016311 T AT05016311 T AT 05016311T AT E457730 T1 ATE457730 T1 AT E457730T1
Authority
AT
Austria
Prior art keywords
products
treatment
administration
microbial infections
synthesis pathway
Prior art date
Application number
AT05016311T
Other languages
English (en)
Inventor
Marc Peters-Golden
Theodore Standiford
Original Assignee
Univ Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Michigan filed Critical Univ Michigan
Application granted granted Critical
Publication of ATE457730T1 publication Critical patent/ATE457730T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT05016311T 1996-12-03 1997-12-03 Verabreichung von produkten des 5-lipoxygenase synthesewegs zur behandlung von mikrobiellen infektionen ATE457730T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/757,136 US5909734A (en) 1996-12-03 1996-12-03 Administration of products of the 5-lipoxygenase metabolic pathway to enhance antimicrobial defense

Publications (1)

Publication Number Publication Date
ATE457730T1 true ATE457730T1 (de) 2010-03-15

Family

ID=25046516

Family Applications (2)

Application Number Title Priority Date Filing Date
AT97954070T ATE307589T1 (de) 1996-12-03 1997-12-03 Verabreichung von produkten des 5- lipoxygenasestoffwechsels zur steigerung der antimikrobiellen abwehr
AT05016311T ATE457730T1 (de) 1996-12-03 1997-12-03 Verabreichung von produkten des 5-lipoxygenase synthesewegs zur behandlung von mikrobiellen infektionen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT97954070T ATE307589T1 (de) 1996-12-03 1997-12-03 Verabreichung von produkten des 5- lipoxygenasestoffwechsels zur steigerung der antimikrobiellen abwehr

Country Status (9)

Country Link
US (3) US5909734A (de)
EP (2) EP1602375B1 (de)
AT (2) ATE307589T1 (de)
AU (1) AU733567B2 (de)
CA (1) CA2278140C (de)
DE (2) DE69734476T2 (de)
DK (1) DK1037640T3 (de)
ES (2) ES2251748T3 (de)
WO (1) WO1998024397A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7473708B2 (en) 1996-02-15 2009-01-06 Jean Gosselin Agents with leukotriene B4-like antiviral (enveloped RNA) activities
US5909734A (en) * 1996-12-03 1999-06-08 Regents Of The University Of Michigan Administration of products of the 5-lipoxygenase metabolic pathway to enhance antimicrobial defense
KR100325581B1 (ko) * 1998-08-07 2002-08-24 오우택 아라키토닉산의리폭시게네이즈대사결과물질을함유하는진통제용조성물
WO2004112795A1 (en) * 2003-06-25 2004-12-29 Ltb4 Sweden Ab Ltb4 compositions for treating tract infections
WO2005102309A2 (en) * 2004-04-26 2005-11-03 Ltb4 Sweden Ab In vivo release of endogenous anti-microbial mediators by leukotriene b4 (ltb4) administration
SI1796730T1 (sl) * 2004-09-20 2010-12-31 Ltb4 Sweden Ab Stabilizirana leukotriene b4 (ltb4) farmacevtska formulacija
NZ720946A (en) 2009-04-29 2017-09-29 Amarin Pharmaceuticals Ie Ltd Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
CN112546196A (zh) * 2020-02-29 2021-03-26 中国人民解放军总医院第三医学中心 肌动蛋白聚合诱导剂在制备抵抗或抑制肺炎克雷伯氏菌的药物中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4821714A (en) * 1986-12-04 1989-04-18 Smelser Danny N Pharmaceutical endotracheal tube
US5314918A (en) * 1987-06-24 1994-05-24 Smithkline Beecham Corporation Leukotriene antagonists
US5145861A (en) * 1987-11-04 1992-09-08 Merrell Dow Pharmaceuticals Inc. Fluorinated arachidonic acid derivatives
WO1993018061A1 (en) * 1992-03-07 1993-09-16 Morinaga Milk Industry Co., Ltd. Immunostimulatory agent
US5674483A (en) * 1995-01-31 1997-10-07 National Jewish Medical And Research Center Treatment for diseases involving inflammation
US5789441A (en) * 1996-02-15 1998-08-04 Virocell Inc. Leukotriene B4 as an antiviral and anti-neoplastic agent
US5909734A (en) * 1996-12-03 1999-06-08 Regents Of The University Of Michigan Administration of products of the 5-lipoxygenase metabolic pathway to enhance antimicrobial defense

Also Published As

Publication number Publication date
DK1037640T3 (da) 2006-03-13
CA2278140A1 (en) 1998-06-11
CA2278140C (en) 2008-02-05
WO1998024397A3 (en) 1998-09-03
DE69739775D1 (de) 2010-04-01
WO1998024397A2 (en) 1998-06-11
ATE307589T1 (de) 2005-11-15
ES2251748T3 (es) 2006-05-01
DE69734476D1 (de) 2005-12-01
AU5794298A (en) 1998-06-29
ES2341255T3 (es) 2010-06-17
US7696148B1 (en) 2010-04-13
EP1037640A2 (de) 2000-09-27
EP1602375B1 (de) 2010-02-17
US5909734A (en) 1999-06-08
US20050267211A1 (en) 2005-12-01
EP1602375A2 (de) 2005-12-07
EP1037640A4 (de) 2003-07-23
EP1602375A3 (de) 2005-12-14
DE69734476T2 (de) 2006-07-13
EP1037640B1 (de) 2005-10-26
AU733567B2 (en) 2001-05-17

Similar Documents

Publication Publication Date Title
GEP20053429B (en) 3-Aminoquinazolin-2,4-Dione, Pharmaceutical Composition Containing Them and Use Thereof as Antibacterial Agents
DE69802260T2 (de) Pharmazeutische Zusammensetzungen enthaltend Lactobacillus brevis und Lactobacillus salivarius zur Behandlung von Vaginainfektionen
NZ506058A (en) Antibacterial 9-substituted tetracyclines, and pharmaceuticals and uses thereof
ATE407687T1 (de) Probiotisches milchsäurebakterium zur behandlung bakterieller infektionen in zusammenhang mit sids
WO2001058465A3 (en) Probiotic therapy for newborns
DE69731309D1 (de) Impfstofformel auf polynukleotidbasis zur behandlung von hundekrankheiten, insbesondere solcher des atmungs- und verdauungstraktes
HK1014155A1 (en) Method of treating gram-negative bacterial infection by administration of bactericidal/permeability-increasing (bpi) protein product and antibiotic
NO991548L (no) Anvendelse av mupirocin for fremstilling av et medikament for behandling av bakterieinfeksjoner forÕrsaket i forbindelse med kolonisering av nasofarynks med patogene organismer
AU1794601A (en) Prevention and treatment of pulmonary bacterial infection or symptomatic pulmonary exposure to endotoxin by inhalation of antiendotoxin drugs
ATE221783T1 (de) Pharmazeutische zusammensetzungen welche lactobacillus plantarum und arginin beinhalten
ATE457730T1 (de) Verabreichung von produkten des 5-lipoxygenase synthesewegs zur behandlung von mikrobiellen infektionen
DE69914911D1 (de) Pharmazeutische präparate zur bekämpfung oder prophylaxe von mikroorganismen infizierten oberflächen
NZ510153A (en) Tan-1057 derivatives with reduced toxicity and their use in medicaments for treating bacterial infections in humans and mammals
ES2136206T3 (es) Composicion antibacteriana que contiene alfalactalbumina multimerica.
EP0966196A4 (de) Zusammensetzung zur organ-kryokonservierung und behandlung von viralen und bakteriellen infektionen
AU5643299A (en) Humic acid and its use in the treatment of various conditions
HUP0003845A2 (hu) Antimikrobiális 8a-azalidok alkalmazása
DE602004017586D1 (de) Medizinische zusammensetzung zur behandlung von infektionen mit arzneimittelresistentem staphylococcus aureus
Czarnecki et al. The use of mupirocin before skin surgery
RU94024111A (ru) Способ профилактики кишечных инфекций
MX9708385A (es) Derivados novedosos de tetraciclina, composiciones que los contienen, y el uso de las mismas.
RU94024117A (ru) Способ лечения гастроэнтероколита
HUP9902828A3 (en) Pharmaceutical composition for killing antibiotic-resistant gram positive bacteria and treatment of infection

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties